We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+0.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4B
AUM Growth
+$261M
Cap. Flow
+$281M
Cap. Flow %
7.02%
Top 10 Hldgs %
19.74%
Holding
679
New
127
Increased
246
Reduced
223
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$104M
2
AAPL icon
Apple
AAPL
+$60.7M
3
AMZN icon
Amazon
AMZN
+$47.5M
4
AXP icon
American Express
AXP
+$28.7M
5
TRV icon
Travelers Companies
TRV
+$27.2M

Top Sells

Rank Stock Value
1
FSLR icon
First Solar
FSLR
+$28.1M
2
JNJ icon
Johnson & Johnson
JNJ
+$28.1M
3
CLX icon
Clorox
CLX
+$26.2M
4
TJX icon
TJX Companies
TJX
+$24.8M
5
MCK icon
McKesson
MCK
+$23.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.39%
2 Financials 11.87%
3 Technology 10.68%
4 Communication Services 10.67%
5 Consumer Discretionary 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LM
151
DELISTED
Legg Mason, Inc.
LM
$6.17M 0.15%
178,865
-172,512
-49% -$5.41M
ECL icon
152
Ecolab
ECL
$75.6B
$6.15M 0.15%
55,455
+20,496
+59% +$2.18M
KYNB
153
Kyntra Bio
KYNB
$28.5M
$6.12M 0.15%
11,560
+1,160
+11% +$578K
UNM icon
154
Unum
UNM
$13.8B
$6M 0.15%
+195,090
New +$5.72M
XYL icon
155
Xylem
XYL
$28.5B
$5.96M 0.15%
146,497
+48,081
+49% +$1.77M
DVN icon
156
Devon Energy
DVN
$51.9B
$5.95M 0.15%
218,176
+116,911
+115% +$2.85M
AES icon
157
AES
AES
$10.6B
$5.91M 0.15%
503,147
+472,627
+1,549% +$4.71M
CTSH icon
158
Cognizant
CTSH
$21.5B
$5.88M 0.15%
94,366
+63,472
+205% +$3.69M
QRVO icon
159
Qorvo
QRVO
$7.63B
$5.87M 0.15%
117,003
-65,816
-36% -$2.87M
EOG icon
160
EOG Resources
EOG
$78B
$5.83M 0.15%
80,788
+60,608
+300% +$4.19M
HON icon
161
Honeywell
HON
$77.1B
$5.79M 0.14%
57,781
-5,455
-9% -$511K
PAYX icon
162
Paychex
PAYX
$40.4B
$5.77M 0.14%
107,361
-22,952
-18% -$1.16M
JCI icon
163
Johnson Controls International
JCI
$87.5B
$5.76M 0.14%
142,026
+108,251
+321% +$4.13M
FDX icon
164
FedEx
FDX
$74.5B
$5.74M 0.14%
35,479
+26,790
+308% +$3.73M
RY icon
165
Royal Bank of Canada
RY
$291B
$5.72M 0.14%
99,338
+11,780
+13% +$611K
PPL
166
PPL Corp
PPL
$27.3B
$5.71M 0.14%
150,800
+122,806
+439% +$4.36M
ABT icon
167
Abbott
ABT
$180B
$5.7M 0.14%
+136,936
New +$5.43M
LUV icon
168
Southwest Airlines
LUV
$22.1B
$5.67M 0.14%
+127,275
New +$5.18M
IYR icon
169
iShares US Real Estate ETF
IYR
$4.59B
$5.64M 0.14%
72,900
EXEL icon
170
Exelixis
EXEL
$13.9B
$5.61M 0.14%
1,410,000
+510,000
+57% +$2.16M
NKTR icon
171
Nektar Therapeutics
NKTR
$2.39B
$5.61M 0.14%
27,333
-6,014
-18% -$1.16M
AIZ icon
172
Assurant
AIZ
$13.7B
$5.53M 0.14%
72,087
-175,855
-71% -$13.3M
AET
173
DELISTED
Aetna Inc
AET
$5.5M 0.14%
49,245
+6,744
+16% +$722K
EWC icon
174
iShares MSCI Canada ETF
EWC
$6.04B
$5.36M 0.13%
227,136
TMO icon
175
Thermo Fisher Scientific
TMO
$211B
$5.33M 0.13%
37,820
+3,190
+9% +$428K

Similar funds

Candriam SCA's Q1 2016 Portfolio in Review

As of Q1 2016, Candriam SCA held 679 positions worth $4B, up 7% from $3.74B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA deployed $281M of net new capital in Q1 2016, opening 127 new positions and adding to 246 existing holdings. Its largest new stake was Amgen: 700,333 shares worth $104M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was First Solar, an estimated $28.1M trimmed.

  • Candriam SCA's largest Q1 2016 buy was Amgen: 700,333 shares worth $104M.
  • Candriam SCA added most to Mead Johnson Nutrition Company in Q1 2016, an estimated $22.2M increase.
  • Candriam SCA's biggest Q1 2016 reduction was First Solar, cutting an estimated $28.1M.
  • Candriam SCA fully exited Avangrid, Inc. in Q1 2016, selling an estimated $9.6M.
  • Candriam SCA's ten largest holdings make up 20% of its $4B portfolio in Q1 2016.
  • Candriam SCA opened 127 new positions and closed 43 in Q1 2016.
  • Candriam SCA's portfolio value rose 7% quarter-over-quarter to $4B.

Based on Candriam SCA's 13F filing for Q1 2016, filed 27 Apr 2016.